SARS-CoV-1 6 binds to NPIPB3

Stable Identifier
R-HSA-9731031
Type
Reaction [binding]
Species
Homo sapiens
Related Species
Human SARS coronavirus
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Severe acute respiratory syndrome coronavirus type 1 (SARS-CoV-1) open reading frame 6 protein (6) antagonizes type I interferon (IFN) production and signaling pathways by blocking nuclear import of signal transducer and activator of transcription 1-alpha/beta (STAT1) (Kopecky‑Bromberg SA et al. 2007; Frieman M et al. 2007). SARS-CoV-1 6 was found to bind to the C-terminal domain of nuclear pore complex-interacting protein family member B3 (NPIPB3) in vitro (Huang SH et al. 2017). Confocal imaging revealed a close co-localization of the viral 6 protein with NPIPB3 in human promonocyte HL-CZ cells. The dual luciferase reporter assay, STAT1 subcellular localization, and Western blotting analysis suggest that the interaction of SARS CoV 6 and NPIPB3 reduced the antagonistic effect of SARS-CoV 6 in HL-CZ cells expressing single or both of 6 and NPIPB3 (Huang SH et al. 2017).
Participants
Participates
Disease
Name Identifier Synonyms
severe acute respiratory syndrome DOID:2945 SARS-CoV infection, SARS
Authored
Reviewed
Created
Cite Us!